CMA imposes substantial fines on pharma firms for overcharging the NHS
Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
Read Moreby Lucy Parsons | Jul 16, 2021 | News | 0
Competition regulator announces fines totalling £260m relating to the supply of hydrocortisone tablets
Read Moreby Selina McKee | Dec 16, 2019 | News | 0
If approved, the firm will be able to offer lifelong treatment for the rare condition congenital adrenal hyperplasia
Read Moreby Selina McKee | Oct 9, 2018 | News | 0
The Scottish Medicines Consortium has endorsed NHS funding for four therapies, offering new treatment options for acute myeloid leukaemia, Still’s disease, adrenal insufficiency and psoriatic arthritis.
Read Moreby Selina McKee | Mar 7, 2017 | News | 0
Concordia and Actavis UK stand accused of breaking UK competition law by artificially lifting the cost of hydrocortisone tablets to the National Health Service with a deal that delayed competition to the drug.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
